Immune response to basal cell and squamous cell carcinomas.

Area of Science:

• Immunology
• Dermatology
• Oncology

Background:

• Basal cell carcinoma (BCC) and squamous cell carcinoma are common skin cancers.
• The immune system's role in skin cancer development and progression is increasingly recognized.
• Understanding immune mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To summarize current understanding of the immune response to basal cell carcinoma and squamous cell carcinoma.
• To explore local and systemic immune mechanisms influencing skin tumor growth.
• To identify potential immune suppressive factors in skin cancer.

Main Methods:

• Review of recent studies on skin cancer immunology.
• Analysis of proposed immune response pathways, including delayed-type hypersensitivity.
• Examination of suppressor cell activity in animal models and human patients.

Main Results:

• Evidence suggests a local immune response analogous to delayed-type hypersensitivity.
• Tumor antigen recognition and cell-mediated immunity are implicated in the anti-tumor response.
• Suppressor cell activity may blunt the immune response, particularly in UV-induced tumors and multiple BCCs.

Conclusions:

• The immune response to skin cancers like BCC and squamous cell carcinoma involves complex local and systemic factors.
• Suppressor cell activity represents a significant mechanism for immune evasion in these cancers.
• Further research is needed to fully elucidate these immune interactions and inform therapeutic strategies.